Pharmaceutical Industry Is Invited to Respond to Amnesty for Unreported Trials

BMJ
doi 10.1136/bmj.315.7109.683b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Pharmaceutical Industry Support for Continuing Medical Education: Is It Time to Disengage?

Journal of Paediatrics and Child Health
Child HealthPediatricsPerinatology
2011English

Clinical Trials: Tamiflu Reviewers Respond to Critics

Nature
Multidisciplinary
2014English

Dr Costain Was Invited to Respond to the Letter by Professor Godfrey

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Matheson. World Supplier to the Pharmaceutical Industry.

Chemical and Engineering News
Chemical Engineering
1981English

DOs Encouraged to Participate in Pharmaceutical, Clinical Trials

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

Dr. Heggers, Author of the Article in Question, Was Invited to Respond to Ms. Scheidt's Comments

Infection Control
1983English

The Authors Respond to “Is It Premature to SPRINT?”

CMAJ
Medicine
2017English

A Review Article on Pharmaceutical Analysis of Pharmaceutical Industry According to Pharmacopoeias

Oriental Journal of Chemistry
BiochemistryEnvironmental ChemistryDrug DiscoveryChemistry
2020English

Importance of Biodiversity to the Modern Pharmaceutical Industry

Pure and Applied Chemistry
ChemistryChemical Engineering
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy